While our ability to collect large amounts of experimental data in a timely and cost-effective manner represented, until recently, a top priority, a different challenge is currently taking shape. Now ...

Artificial intelligence can design toxins that evade security controls. A team at Microsoft says it used artificial ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ('INBS' or the 'Company'), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today provided an update on its FDA ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company unlocking the human body’s own power to cure disease, today unveiled $4.3 million in seed funding. The investment capital has enabled ...

The drug-testing system screens fingerprint sweat for recent use of drugs, returning results in under ten minutes, the New York company said. Intelligent Bio said it is currently evaluating the FDA's ...

Peptide mapping analysis of protein digestions is a critical component of biopharmaceutical development and manufacturing. The demanding method conditions required to perform these complex separations ...

Biopharmaceutical companies are often progressing several monoclonal antibody (mAb) drug candidates to mitigate the risks associated with drug development. This strategic approach, aimed at increasing ...

The POSTECH-Catholic University Medical Biotechnology Research Institute, which has led the convergence research of domestic ...

CN Bio, a leading developer of single and multi organ-on-chip microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery, today announced the publication of ...

Feb 19 (Reuters) - Diagnostics company Bio-Rad (BIO.N), opens new tab has been sued by the California Institute of Technology for allegedly misusing the school's patented technology for analyzing ...